Sun Pharmaceutical Industries Ltd 2025 SR
The report for FY2024-25 highlights Sun Pharma's inclusion in the S&P Global Sustainability Yearbook 2025, ranking in the top 5% of global pharmaceutical companies. The company achieved a 24.69% reduction in absolute Scope 1 and 2 emissions against a 2020 baseline, with renewable energy now comprising 49.77% of its energy mix. It also surpassed its 2025 water reduction target early, reaching a 31.70% reduction. Social initiatives included spending ₹508.34 million on CSR, impacting over 1 million lives, and setting a target for 30% women representation in the global workforce by 2040.
Company: Sun Pharmaceutical Industries Ltd
Sector: Health Care
Country: India
Year: 2025
Type: SR
Pages: 42
Sun Pharmaceutical Industries Ltd
Business Responsibility And Sustainability Report
The report for FY2024-25 highlights Sun Pharma's inclusion in the S&P Global Sustainability Yearbook 2025, ranking in the top 5% of global pharmaceutical companies. The company achieved a 24.69% reduction in absolute Scope 1 and 2 emissions against a 2020 baseline, with renewable energy now comprising 49.77% of its energy mix. It also surpassed its 2025 water reduction target early, reaching a 31.70% reduction. Social initiatives included spending ₹508.34 million on CSR, impacting over 1 million lives, and setting a target for 30% women representation in the global workforce by 2040.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Apr 1, 2024 - Mar 31, 2025
Fiscal Year
2025
Published
Jun 27, 2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees